First Rituxan biosimilar Truxima set to make its debut in USBiosimilar competition to Roche’s big-selling Rituxan has arrived in the US, with Teva gearing up to launch its Share XFirst Rituxan biosimilar Truxima set to make its debut in UShttps://pharmaphorum.com/news/first-rituxan-biosimilar-truxima-set-to-makes-its-debut-in-us/
Teva’s strategy for multichannel engagementTeva has a simple strategy for multichannel customer relationship management (CRM) and at its heart is the alignment Share XTeva’s strategy for multichannel engagementhttps://pharmaphorum.com/sales-marketing/tevas-strategy-for-multichannel-engagement/
Federal opioid trial averted by last-ditch settlementTeva and three pharma wholesalers have agreed a $260 million settlement with two Ohio counties over their role Share XFederal opioid trial averted by last-ditch settlementhttps://pharmaphorum.com/news/federal-opioid-trial-averted-by-last-ditch-settlement/
Is the US opioid litigation nearing an end game?Drugmakers, wholesalers and lawmakers in the US are said to be thrashing out the details of a big Share XIs the US opioid litigation nearing an end game?https://pharmaphorum.com/news/is-the-us-opioid-litigation-nearing-an-end-game/
EU clears GSK’s asthma drug Nucala in patient-friendly formatWith competition heating up in the severe asthma category, GlaxoSmithKline has a new EU approval that it hopes Share XEU clears GSK’s asthma drug Nucala in patient-friendly formathttps://pharmaphorum.com/news/eu-clears-gsks-asthma-drug-nucala-in-patient-friendly-format/
Teva expands blood pressure drug recall in the US amid cancer fearsTeva has expanded a recall of losartan potassium tablets after tests revealed a potential human carcinogen in the Share XTeva expands blood pressure drug recall in the US amid cancer fearshttps://pharmaphorum.com/news/teva-expands-blood-pressure-drug-recall-in-the-us-amid-cancer-fears/
Teva settles Oklahoma opioid lawsuit ahead of trialTeva has opted to settle the first trial among hundreds of cases that accuse it and other drugmakers Share XTeva settles Oklahoma opioid lawsuit ahead of trialhttps://pharmaphorum.com/news/teva-settles-oklahoma-opioid-lawsuit-ahead-of-trial/
Teva vows to fight price-fixing lawsuitTeva has said it will defend itself against a lawsuit raised by 44 US states that alleges the Share XTeva vows to fight price-fixing lawsuithttps://pharmaphorum.com/news/teva-vows-to-fight-price-fixing-lawsuit/
Novartis sues as Amgen tries to cancel migraine tie-upNovartis and Amgen have become embroiled in a legal row over rights to the migraine prevention drug Aimovig, Share XNovartis sues as Amgen tries to cancel migraine tie-uphttps://pharmaphorum.com/news/novartis-sues-as-amgen-tries-to-cancel-migraine-tie-up/
